There was a significant difference in the KIT mutation rate among GIST patients in the Ki67 status group of ≤5, group of >5 and <10, and group of ≥10 (p = 0.001333) (Table 4). This evidence concerns the gene MKI67 and gastrointestinal stromal tumor.